HADEEL DELMAN NAJIM; MOHAMMED MAHMOOD MOHAMMED; ABBAS MAHDI RAHMAH. Influence of Adding Empagliflozin to Conventional Anti-diabetic Therapy on Quality of Life Scale for Type 2 Diabetic Patients. Iraqi Journal of Pharmaceutical Sciences, Baghdad, Iraq, v. 33, n. 3, p. 142–149, 2024. DOI: 10.31351/vol33iss3pp142-149. Disponível em: https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/2742.. Acesso em: 21 nov. 2024.